Title: The Tetravalent Death Receptor 5 Agonist Ozekibart (INBRX-109) in Patients With Chondrosarcoma: Updated Results From a Phase 1 Study
Lead Author: Sant P. Chawla
Abstract: P95
Poster presentation Thursday, November 14 – Saturday, November 16, 2024

Title: PERK Endoplasmic Reticulum (ER) Stress is a Key Modulator of TMZ-Induced Activation of the DR5 Mediated Apoptotic Pathway in Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumor (GIST)
Lead Author: Shashwath Kalladi Malli
Abstract: Paper 59
Oral presentation on Friday, November 15, 2024 from 2:00-3:00 PM PST

INBRX-109 Updated Phase 1 Chondrosarcoma

1.3 MB

SDH-def GIST Models INBRX-109 plus TMZ

2.7 MB